Apoptosis Resistance of Nonobese Diabetic Peripheral Lymphocytes Linked to the Idd5 Diabetes Susceptibility Region

Defects in lymphocyte apoptosis may lead to autoimmune disorders and contribute to the pathogenesis of type 1 diabetes. Lymphocytes of nonobese diabetic (NOD) mice, an animal model of autoimmune diabetes, have been found resistant to various apoptosis signals, including the alkylating drug cyclophos...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 94; no. 16; pp. 8670 - 8674
Main Authors Colucci, Francesco, Bergman, Marie-Louise, Penha-Goncalves, Carlos, Cilio, Corrado M., Holmberg, Dan
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 05.08.1997
National Acad Sciences
National Academy of Sciences
The National Academy of Sciences of the USA
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Defects in lymphocyte apoptosis may lead to autoimmune disorders and contribute to the pathogenesis of type 1 diabetes. Lymphocytes of nonobese diabetic (NOD) mice, an animal model of autoimmune diabetes, have been found resistant to various apoptosis signals, including the alkylating drug cyclophosphamide. Using an F2intercross between the apoptosis-resistant NOD mouse and the apoptosis-susceptible C57BL/6 mouse, we define a major locus controlling the apoptosis-resistance phenotype and demonstrate its linkage (logarithm of odds score = 3.9) to a group of medial markers on chromosome 1. The newly defined gene cannot be dissociated from Ctla4 and Cd28 and in fact marks a 20-centimorgan region encompassing Idd5, a previously postulated diabetes susceptibility locus. Interestingly, we find that the CTLA-4 (cytotoxic T lymphocyte-associated antigen 4) and the CD28 costimulatory molecules are defectively expressed in NOD mice, suggesting that one or both of these molecules may be involved in the control of apoptosis resistance and, in turn, in diabetes susceptibility.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
F.C. and M.-L.B. contributed equally to this work.
To whom reprint requests should be sent at the present address: Department of Immunology, Immunobiology Unit, 25, rue du Dr. Roux, 75015 Paris, France. e-mail: holmberg@pasteur.fr.
N. Avrion Mitchison, Deutsches RheumaForschungsZentrum Berlin, Berlin, Germany
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.94.16.8670